MoleSense advances women’s healthcare with molecular wearables—a new class of medical devices that go beyond tracking vital signs to continuously and non-invasively monitor biochemical markers such as proteins and hormones.
By integrating personalized molecular data with biology-aware machine intelligence, our wearables provide proactive healthcare for high-risk pregnancies.
04.02.2026
MoleSense wins over Vanguard Accelerator (startupticker.ch)
08.12.2025
Forbes 30Under30 spotlights Swiss innovators (startupticker.ch)
04.12.2025
Swiss innovators garner recognition (startupticker.ch)
01.12.2025
MoleSense gewinnt Swiss Innovation Challenge 2025 (startupticker.ch)
29.10.2025
MoleSense to advance the first molecular wearable for maternity care (startupticker.ch)
No milestones
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.molesense.ch/
Headquarter:
Epalinges
Technology:
Sectors: